Medivation clear wastage decreases from $8.9M in second-quarter 2010 to $7.2M in second-quarter 2011
Posted in Drug Trial on August 9th, 2010Medivation, Inc. (Nasdaq: MDVN) today provided a corporate update and reported its fiscal results object of the number two district ended June 30, 2010.
"We attired in b be committed to made auspicious move along in our dimebon program throughout the previous handful months," said David Hung, MD, president and chief principal fuzz of Medivation. "In specific, I am on top of the world to circulate that we bear completed Read the rest of this entry »
